Universitaetsklinikum Augsburg — Clinical Trial Site

185 Registered trials

95 Currently recruiting

Organisation

Universitaetsklinikum Augsburg

Location

Augsburg, Germany

Identifier

ORG-100029226

Address

Stenglinstrasse 2, Kriegshaber, 86156, Germany

Departments

"Schwäbisches Kinderkrebszentrum Kinderkrebsforschungszentrum"
#2052:II. Medizinische Klinik
#3144: Klinik für Frauenheilkunde und Geburtsmedizin
1408: Haematologie,Onkologie
1906:Klinik für Kinder- und Jugendmedizin
2057: Klinik für Kinder- und Jugendmedizin
2515: II Medizinische Klinik
2614: Klinik für Urologie
3131:Klinik für Nuklearmedizin
Anesthesiology and Intensive Care Medicine
Apotheke
Children’s Cancer Center
Clinic for Children and Adolescent Medicine
Clinic for Dermatology, Venerology and Allergology
Clinic for Paediatric and Adolescent Medicine
Clinic for Pediatrics and Adolescent Medicine
Comprehensive Cancer Center Augsburg - CCCA
DE10032: Klinikum Augsburg - III. Med. Klinik
Department o Medicine II, Hematology/Oncology
Department of Anesthesiology and Intensive Care Medicine
Department of Dermatology
Department of Medicine II
Department of Neurology
Dept. für Dermatologie und Allergologie
Dermatologie
Dermatology
Dermatology and Allergology
DermatoOncology
Frauenklinik
Gastroenterologie
Gastroenterology
Gastrointestinale Onkologie
Gynecology
Gynecology and Obstetrics
Hämatologie / Onkologie
Hochschulambulanz für Strahlentherapie und Radioonkologie
I. Klinik fuer Kinder und Jugendliche
I. Medizinische Klinik
II Deparment of internal medicine, Hematology/ Oncology
II Department of Internal Medicine, Hematology / Oncology
II Medical Clinic Hematologic, Oncologic Department
II Medizinische Klinik Hämatologie/ Onkologie
II. Klinik für Kinder und Jugendliche
II. Med. Klinik
II. Medical Clinic
II. Medical Clinic - Haematology/Oncology
II. Medizinische Klinik
II. Medizinische Klinik Hämatologie und Internistische Onkologie
II. Medizinische Klinik Cancer Center Augsburg
II. Medizinische Klinik für Innere Medizin, Hämatologie, Onkologie, Palliativmedizin
II. Medizinische Klinik, Haematologie, internistische Onkologie und Haemostaseologie
II. Medizinische Klinik, Hämatologie, Onkologie
II. Medizinische Klinik, Hämatologie/Onkologie
II.medizinische Klinik/Hämatologie, Onkologie
III med Klinik
III Medizinische Klinik / Gastroenterologie und Gastrointestinale Onkologie
III. Med. Klinik
III. Medical Clinic, Gastroenterology
III. Medizinische Klinik
III. Medizinische Klinik - Gastroenterologie und Gastrointestinale Onkologie
III. Medizinische Klinik; Hämatologie und Internistische Onkologie
Innere Medizin Schwerpunkt Hämatologie und Onkologie
Innere Medizin und hämatologie und Onkologie in Augsburg
Innere Medizin, Haematologie und Onkologie
Internal Medicine
Internal Medicine, Haematology and Oncology
Kinderklinik
Klinik fuer Dermatologie
Klinik fuer Dermatologie und Allergologie
Klinik fuer Hals-, Nasen-, und Ohrenheilkunde
Klinik fuer Kinder- und Jugendmedizin
Klinik fuer Neurochirurgie
Klinik fuer Urologie
Klinik für Anästhesiologie und Operative Intensivmedizin
Klinik für Dermatologie
Klinik für Dermatologie und Allergologie
Klinik für Dermatologie und Allergologie, Campus Süd
Klinik für Frauenheilkunde
Klinik für Frauenheilkunde und Geburtshilfe
Klinik für Frauenheilkunde und Geburtsmedizin
Klinik für Kinder- und Jugendliche
Klinik für Kinder- und Jugendmedizin
Klinik für Kinder- und Jugendmedizin Schwäbisches Kinderkrebszentrum
Klinik für Kinder- und Jugendmedizin, Schwäbisches Kinderkrebszentrum
Klinik für Neurologie und klinische Neurophysiologie
Klinik für Nuklearmedizin
Klinik für Strahlentherapie
Klinik für Urologie
Medizinische Klinik II
Medizinische Klinik II, Stammzelltransplantation
Medizinische Klinik III
N/A
NA
Neuroradiologie
Nuclear Medicine
Paedriatrics, Department of Oncology and Hematology
Pediatric Hematology/Oncology
Pediatrics and adolescent medicine
Pedriatrics
Schwäbisches Kinderkrebszentrum
Schwäbisches Kinderkrebszentrum I. Klinik für Kinder und Jugendliche Hämatologie / Onkologie
Schwäbisches Kinderkrebszentrum Kinderkrebsforschungszentrum
Universitaetsklinikum Augsburg
Universitätsklinikum Augsburg A.ö.R.
Universitätsklinikum Augsburg Brustzentrum
Universitätsklinikum Augsburg, II. Medizinische Klinik-Hämatologie, Onkologie
University Hospital Augsburg III. med. Clinic

Clinical trials at this site (185)

Search interface

FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma Recruiting

2024-510579-40-00 Rhabdoyosarcoma 9 2020-10-07
Midostaurin + Gemtuzumab Ozogamicin combination in first-line standard therapy for acute myeloid leukemia (MOSAIC) Recruiting

2024-514014-13-00 female and male adult patients with acute myeloid leuke 9 2020-09-02
SIOP RANDOMET 2017 Recruiting

2023-508926-91-00 Stage IV childhood renal tumour with pulmonary +/- non- 5 2019-12-05
LBL 2018 - International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma Recruiting

2023-508101-24-00 Lymphoblastic lymphoma 5 2019-08-01
INFORM2 exploratory multinational phase I/II combination study of Nivolumab and Entinostat in children and adolescents with refractory high-… Recruiting

2024-514409-78-01 relapsed / refractory or progressive high risk malignan 9 2019-07-26
Paediatric Hepatic International Tumour Trial Recruiting

2024-516110-38-00 Hepatoblastoma and Hepatocellular Carcinoma 5 2018-03-06
Study to allow access to dabrafenib and/or trametinib for subjects that are benefiting from dabrafenib and/or trametinib treatment in a Nova… Recruiting

2023-509318-13-00 Multiple indications 6 2018-01-15
Effect of high-dose vitamin D on 28-day mortality in adult critically ill patients with severe vitamin D deficiency Recruiting

2024-514556-32-00 Adult critically ill patients with severe vitamin D def 5 2017-02-15
SIOP Ependymoma II: An International Clinical Program for the diagnosis and treatment of children, adolescents and young adults with ependym… Recruiting

2024-512222-28-00 Newly diagnosed with an intracranial or spinal ependymo 10 2015-06-02
A trial to learn more about the effects of ribociclib taken with endocrine therapy in patients with early breast cancer. Ended

2022-503001-38-01 HR-positive HER-2- negative Breast Cancer 5 2025-07-08
A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis Ended

2024-510753-10-00 Prurigo Nodularis 5 2024-11-01
A Study to Evaluate the Safety and Effectiveness of APG777 in Subjects with Atopic Dermatitis Ended

2024-511260-84-00 Atopic Dermatitis 4 2024-09-03
A Study to Compare the Efficacy and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants with Previously Untreated High-… Ended

2023-510178-15-00 High-risk Large B-cell Lymphoma 5 2024-07-31
MTR² Ended

2022-502790-42-00 Primary Central Nervous Lymphoma (PCNSL) 4 2024-06-24
Individualized Immunotherapy in Early-Stage Unfavorable Classical Hodgkin Lymphoma Ended

2022-500571-32-00 Early-Stage Unfavorable Classical Hodgkin Lymphoma 4 2024-05-15
A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate-to-Severe Atopic Dermatitis (REZOLV… Ended

2023-507456-69-00 Atopic Dermatitis 4 2024-04-25
TRAP-BTC Efficacy and safety of GemCis plus Trastuzumab plus Pembrolizumab in previously untreated HER2-positive biliary tract cancer Ended

2023-505722-33-00 cholangiocarcinoma or gallbladder carcinoma 4 2024-04-15
A Phase 3 Randomized Study Comparing Talquetamab in Combination with Pomalidomide (Tal-P), Talquetamab in Combination with Teclistamab (Tal-… Ended

2022-502446-27-00 Relapsed or Refractory Myeloma 5 2024-02-26
NeoAdjuvant Dynamic marker - Adjusted Personalized Therapy comparing trastuzumab-deruxtecan versus pacli-/docetaxel+carboplatin+trastuzumab+… Ended

2024-514458-61-01 HER2+ early breast cancer 4 2024-02-05
A Study of an Intermittent ADT Approach with Apalutamide Monotherapy in Participants with mCSPC Ended

2022-502686-24-00 Metastatic Castration-Sensitive Prostate Cancer (mCSPC) 5 2023-11-22
Combined Pembrolizumab and Lenvatinib after definitive Chemoradiation of locally advanced HNSCC in PD-L1 positive patients (CPS≥1) Ended

2024-516536-10-00 Locally advanced head and neck squamous cell carcinoma 4 2023-05-25
LOGGIC/FIREFLY-2: DAY101 vs. Standard of Care Chemotherapy in Pediatric Patients with Low-Grade Glioma Requiring First-Line Systemic Therapy Ended

2024-510742-13-00 Pediatric low-grade glioma harboring an activating RAF 5 2023-04-19
A Study of Dato-DXd With or Without Durvalumab Versus Investigator’s Choice of Therapy in Patients With Stage I-III Triple-negative Breast C… Ended

2023-505552-22-00 Stage I-III Triple-negative Breast Cancer with residual 5 2023-02-24
A Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With N… Ended

2024-510947-71-00 Chronic Myeloid Leukemia 5 2022-11-21